Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $527.9700 (2.94%) ($514.9750 - $533.1700) on Thu. Jun. 18, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.54% (three month average) | RSI | 11 | Latest Price | $527.9700(2.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.1% a day on average for past five trading days. | Weekly Trend | REGN advances 0.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(37%) XBI(36%) QQQ(30%) SPY(29%) | Factors Impacting REGN price | REGN will decline at least -6.27% in a week (0% probabilities). VIXM(-11%) TLT(-6%) UUP(-3%) SHY(-2%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.27% (StdDev 12.54%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
5 Day Moving Average | $506.79(4.18%) | 10 Day Moving Average | $463.78(13.84%) | 20 Day Moving Average | $486.45(8.54%) | To recent high | -2.1% | To recent low | 20.5% | Market Cap | $55.98b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |